NADIM ADJUVANT Trial Highlights Advantages of Chemo-Immunotherapy After Surgery in Stage IB–IIIA NSCLC
Interim findings from the NADIM ADJUVANT Phase III clinical trial conducted by the Spanish Lung Cancer Group (GECP) have unveiled ...
Tag: non-small cell lung cancer (NSCLC)
Neopred: AI-Driven Dual-Phase CT Tool Enhances Preoperative Prediction of Pathological Response in NSCLC
In a landmark advancement poised to reshape the therapeutic landscape for non-small cell lung cancer (NSCLC), researchers led by Professor ...
Revealing the Inverse Relationship of KLRG1 and PD-1 in Tumor Infiltrating CD8 T Cells
In the evolving landscape of cancer treatment, the intricate interaction between immune cells and tumor microenvironments remains a focal point ...
